A targeted correction to a 2015 inflammation review

Nature Medicine has published an author correction to a 2015 review article on innate lymphoid cells and their roles in the initiation, regulation and resolution of inflammation. The amendment addresses one description in the section titled “ILC2s and metabolic homeostasis.”

The original article, written by Gregory F. Sonnenberg and David Artis, was first published online on 29 June 2015. The correction was published on 10 November 2026 and identifies a specific terminology error in the original text.

What changed

The review had referred to Ucp1 as a transcription factor. Nature Medicine’s correction states that this should instead have described Ucp1 as a mitochondrial carrier protein.

The notice does not describe a change to the article’s authorship, overall subject, or central framing. It serves to amend that single error in the wording used in the section on ILC2s and metabolic homeostasis.

Why precision matters in scientific reviews

Review articles synthesize and explain bodies of research for readers who may use them to orient future experiments, clinical questions or teaching. In that setting, accurate descriptions of biological components matter even when a correction is narrowly scoped.

Calling a molecule a transcription factor describes it as a regulator of gene expression. Describing it as a mitochondrial carrier protein instead places it in a different functional category. The correction therefore makes the terminology used in the review consistent with the function specified in the updated record.

The case is also a reminder that corrections are part of the scientific publishing process. A correction notice preserves the original article’s record while clearly documenting the amendment, rather than silently changing the historical publication without explanation.

The article and its authors

The corrected review, “Innate lymphoid cells in the initiation, regulation and resolution of inflammation,” was authored by Sonnenberg and Artis. Both authors are affiliated with Weill Cornell Medical College in New York, including its Department of Medicine, Division of Gastroenterology and Hepatology, and its Department of Microbiology and Immunology. They are also affiliated with the Jill Roberts Institute for Research in Inflammatory Bowel Disease.

Nature Medicine identifies Sonnenberg as the corresponding author for the correction. The notice links the amendment directly to the original 2015 article and specifies the section in which the wording appeared.

What readers should take from the notice

The correction is narrow: Ucp1 should be described as a mitochondrial carrier protein rather than as a transcription factor. Readers consulting the original review, particularly its discussion of ILC2s and metabolic homeostasis, should use the corrected description.

The publication of a formal correction gives readers a durable, citable record of the change. It also illustrates a basic publishing principle: even established articles can require updates when a term is found to be inaccurate. In this case, the journal has made the scope of the amendment explicit and tied it to the original article’s permanent record.

This article is based on reporting by Nature Medicine. Read the original article.

Originally published on nature.com